CoChat

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

Open access

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

The hormone calcitonin (CT) is primarily known for its pharmacologic action as an inhibitor of bone resorption, yet CT-deficient mice display increased bone formation. These findings raised the question about the underlying cellular and molecular mechanism of CT action. Here we show that either ubiquitous or osteoclast-specific inactivation of the murine CT receptor (CTR) causes increased bone formation. CT negatively regulates the osteoclast expression of Spns2 gene, which encodes a transporter for the signalling lipid sphingosine 1-phosphate (S1P). CTR-deficient mice show increased S1P levels, and their skeletal phenotype is normalized by deletion of the S1P receptor S1P 3 . Finally, pharmacologic treatment with the nonselective S1P receptor agonist FTY720 causes increased bone formation in wild-type, but not in S1P 3 -deficient mice. This study redefines the role of CT in skeletal biology, confirms that S1P acts as an osteoanabolic molecule in vivo and provides evidence for a pharmacologically exploitable crosstalk between osteoclasts and osteoblasts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms6215

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Inactivation of the CTR specifically increases osteoblast function. (a) Immunohistochemistry for the CTR (stained in green) in kidney and hypothalamus (hypoth.) sections from wild-type and Calcr−/− mice. Scale bars, 50 μm (top) and 200 μm (bottom). (b) Binding of 125I-salmon CT to osteoclasts or osteoblasts of the indicated genotypes. The dotted red line represents nonspecific binding; n=3 cultures per group. *P<0.05 versus wild-type. Data are representative of two independent experiments. (c) Quantification of dentin resorption by wild-type and Calcr−/− osteoclasts differentiated in the absence or presence of CT; n=3 cultures per group. *P<0.05 versus control. Data are representative of three independent experiments. (d) Von Kossa/van Gieson-staining of non-decalcified spine sections from 3-month-old female wild-type and Calcr−/− mice (scale bars, 1 mm). (e) Histomorphometric quantification of the trabecular bone volume per tissue volume (BV/TV), the osteoblast number per bone perimeter (ObN/Bpm), the osteoclast number per bone perimeter (OcN/Bpm) and the bone formation rate per bone surface (BFR/BS). Concentrations of osteocalcin and collagen degradation products (crosslaps) were measured in serum; n=6 mice per group. *P<0.05 versus wild-type. (f) Histomorphometric assessment of BV/TV, BFR/BS and serum crosslaps in 6-, 12- and 18-month-old female wild-type and Calcr−/− mice, and of 6-month-old Calcr+/− mice; n=6 mice per group. *P<0.05 versus wild-type. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 1 Inactivation of the CTR specifically increases osteoblast function. (a) Immunohistochemistry for the CTR (stained in green) in kidney and hypothalamus (hypoth.) sections from wild-type and Calcr−/− mice. Scale bars, 50 μm (top) and 200 μm (bottom). (b) Binding of 125I-salmon CT to osteoclasts or osteoblasts of the indicated genotypes. The dotted red line represents nonspecific binding; n=3 cultures per group. *P<0.05 versus wild-type. Data are representative of two independent experiments. (c) Quantification of dentin resorption by wild-type and Calcr−/− osteoclasts differentiated in the absence or presence of CT; n=3 cultures per group. *P<0.05 versus control. Data are representative of three independent experiments. (d) Von Kossa/van Gieson-staining of non-decalcified spine sections from 3-month-old female wild-type and Calcr−/− mice (scale bars, 1 mm). (e) Histomorphometric quantification of the trabecular bone volume per tissue volume (BV/TV), the osteoblast number per bone perimeter (ObN/Bpm), the osteoclast number per bone perimeter (OcN/Bpm) and the bone formation rate per bone surface (BFR/BS). Concentrations of osteocalcin and collagen degradation products (crosslaps) were measured in serum; n=6 mice per group. *P<0.05 versus wild-type. (f) Histomorphometric assessment of BV/TV, BFR/BS and serum crosslaps in 6-, 12- and 18-month-old female wild-type and Calcr−/− mice, and of 6-month-old Calcr+/− mice; n=6 mice per group. *P<0.05 versus wild-type. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central
Figure 2 Phenotypic differences between Calcr−/− and Calca−/− mice. (a) μCT scans of the femur from 18-month-old female Calcr−/− and Calca−/− mice. Scale bar, 500 μm. Cortical porosity for mice of the indicated genotypes is shown on the right; n=5. *P<0.05 versus wild-type. (b) μCT scans of the calvaria from 18-month-old female Calcr−/− and Calca−/− mice. Scale bar, 1 mm. Calvarial porosity for mice of the indicated genotypes is shown on the right; n=5. *P<0.05 versus wild-type. (c) Calvarial porosity induced by local LPS injection in 6 weeks old wild-type, Calcr−/−, Calca−/− and αCGRP−/− mice; n=5. *P<0.05 versus control. #P<0.05 versus wild-type. (d) Osteoclast numbers in wild-type and Calca−/− mice with or without LPS treatment; n=5. *P<0.05 versus control. #P<0.05 versus wild-type. (e) TRAP-positive multinucleated cells (TRAP+MNCs) per visual field (VF) after differentiation of bone marrow cells with M-CSF and RANKL in the presence or absence of 10−8 M PCT; n=3; *P<0.05 versus non-treated wild-type. Data are representative of two independent experiments. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 2 Phenotypic differences between Calcr−/− and Calca−/− mice. (a) μCT scans of the femur from 18-month-old female Calcr−/− and Calca−/− mice. Scale bar, 500 μm. Cortical porosity for mice of the indicated genotypes is shown on the right; n=5. *P<0.05 versus wild-type. (b) μCT scans of the calvaria from 18-month-old female Calcr−/− and Calca−/− mice. Scale bar, 1 mm. Calvarial porosity for mice of the indicated genotypes is shown on the right; n=5. *P<0.05 versus wild-type. (c) Calvarial porosity induced by local LPS injection in 6 weeks old wild-type, Calcr−/−, Calca−/− and αCGRP−/− mice; n=5. *P<0.05 versus control. #P<0.05 versus wild-type. (d) Osteoclast numbers in wild-type and Calca−/− mice with or without LPS treatment; n=5. *P<0.05 versus control. #P<0.05 versus wild-type. (e) TRAP-positive multinucleated cells (TRAP+MNCs) per visual field (VF) after differentiation of bone marrow cells with M-CSF and RANKL in the presence or absence of 10−8 M PCT; n=3; *P<0.05 versus non-treated wild-type. Data are representative of two independent experiments. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central
Figure 3 Control of bone formation by the CTR in osteoclasts. (a) Immunohistochemistry for the presence of the CTR in hypothalamus sections. Scale bar, 200 μm. (b) Binding of 125I-sCT to differentiated osteoclasts derived from mice of the indicated genotypes. The dotted red line represents binding to Calcrfl/fl osteoclasts; n=3 cultures per group. *P<0.05 versus Calcrfl/fl osteoclasts. Data are representative of two independent experiments. (c) Quantification of BV/TV, ObN/Bpm, BFR/BS, OcN/Bpm and measurement of serum crosslaps in 12-month-old female mice of the genotypes indicated above; n≥5 mice per group. *P<0.05 versus Calcrfl/fl mice. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 3 Control of bone formation by the CTR in osteoclasts. (a) Immunohistochemistry for the presence of the CTR in hypothalamus sections. Scale bar, 200 μm. (b) Binding of 125I-sCT to differentiated osteoclasts derived from mice of the indicated genotypes. The dotted red line represents binding to Calcrfl/fl osteoclasts; n=3 cultures per group. *P<0.05 versus Calcrfl/fl osteoclasts. Data are representative of two independent experiments. (c) Quantification of BV/TV, ObN/Bpm, BFR/BS, OcN/Bpm and measurement of serum crosslaps in 12-month-old female mice of the genotypes indicated above; n≥5 mice per group. *P<0.05 versus Calcrfl/fl mice. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central
Figure 4 CT inhibits S1P release from osteoclasts. (a) qRT–PCR expression analysis for the indicated genes during differentiation of wild-type and Calcr−/− bone marrow cells into osteoclasts; n=3 cultures per group. (b) qRT–PCR expression analysis for the indicated genes during differentiation of wild-type and Calcr−/− bone marrow cells into osteoblasts; n=3 cultures per group. (c) Affymetrix signal intensities (relative to control) for selected genes in wild-type and Calcr−/− osteoclasts incubated in the absence or presence of CT; n=3 cultures per group. *P<0.05 versus untreated Calcr+/+ osteoclasts. (d) qRT–PCR expression analysis for the indicated genes during differentiation of wild-type osteoclasts; n=4 cultures per group. *P<0.05 versus day 1. Data are representative of three independent experiments. (e) Immunohistochemistry for SPNS2 in an iliac crest biopsy section from a skeletal-intact donor. Scale bar, 20 μm. (f) Intracellular S1P concentrations in osteoclast precursors or differentiated wild-type osteoclasts incubated with or without CT for 24 h; n=3 cultures per group. *P<0.05 versus untreated osteoclasts. Data are representative of two independent experiments. (g) qRT–PCR expression analysis for Calcr, Sphk1 and Spns2 in wild-type and Calcr−/− osteoclasts incubated with CT for the indicated time; n=4 cultures per group. *P<0.05 versus control. Data are representative of three independent experiments. (h) Extracellular S1P concentrations in conditioned medium of wild-type and Calcr−/− osteoclast precursors (Ocl prec.) or differentiated osteoclasts incubated with or without CT for 24 h; n=3 cultures per group. *P<0.05 versus untreated osteoclasts. Data are representative of three independent experiments. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 4 CT inhibits S1P release from osteoclasts. (a) qRT–PCR expression analysis for the indicated genes during differentiation of wild-type and Calcr−/− bone marrow cells into osteoclasts; n=3 cultures per group. (b) qRT–PCR expression analysis for the indicated genes during differentiation of wild-type and Calcr−/− bone marrow cells into osteoblasts; n=3 cultures per group. (c) Affymetrix signal intensities (relative to control) for selected genes in wild-type and Calcr−/− osteoclasts incubated in the absence or presence of CT; n=3 cultures per group. *P<0.05 versus untreated Calcr+/+ osteoclasts. (d) qRT–PCR expression analysis for the indicated genes during differentiation of wild-type osteoclasts; n=4 cultures per group. *P<0.05 versus day 1. Data are representative of three independent experiments. (e) Immunohistochemistry for SPNS2 in an iliac crest biopsy section from a skeletal-intact donor. Scale bar, 20 μm. (f) Intracellular S1P concentrations in osteoclast precursors or differentiated wild-type osteoclasts incubated with or without CT for 24 h; n=3 cultures per group. *P<0.05 versus untreated osteoclasts. Data are representative of two independent experiments. (g) qRT–PCR expression analysis for Calcr, Sphk1 and Spns2 in wild-type and Calcr−/− osteoclasts incubated with CT for the indicated time; n=4 cultures per group. *P<0.05 versus control. Data are representative of three independent experiments. (h) Extracellular S1P concentrations in conditioned medium of wild-type and Calcr−/− osteoclast precursors (Ocl prec.) or differentiated osteoclasts incubated with or without CT for 24 h; n=3 cultures per group. *P<0.05 versus untreated osteoclasts. Data are representative of three independent experiments. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central
Figure 5 S1P3 controls bone formation. (a) qRT–PCR expression analysis for the indicated genes in primary osteoblasts (Obl) or osteoclasts (Ocl) at different days of differentiation (ND, non-detectable). Data are representative of two independent experiments. (b) Quantification of BV/TV, ObN/Bpm, BFR/BS, OcN/Bpm and measurement of serum crosslaps in 3- and 8-month-old female wild-type and S1pr3−/− mice; n=5 mice per group. *P<0.05 versus wild-type. (c) Quantification of mineralization in wild-type and S1pr3−/− primary osteoblasts differentiated for 10 days in the presence of conditioned medium from wild-type osteoclast precursors (Ocl prec.; control) or differentiated osteoclasts being incubated in the absence or presence of CT; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (d) Quantification of mineralization in wild-type and S1pr3−/− primary osteoblasts differentiated for 10 days in the absence or presence of S1P; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (e) Western Blot monitoring Erk1/2 phosphorylation in wild-type and S1pr3−/− primary osteoblasts with or without S1P treatment for 15 min (uncropped blots are presented in Supplementary Fig. 5). All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 5 S1P3 controls bone formation. (a) qRT–PCR expression analysis for the indicated genes in primary osteoblasts (Obl) or osteoclasts (Ocl) at different days of differentiation (ND, non-detectable). Data are representative of two independent experiments. (b) Quantification of BV/TV, ObN/Bpm, BFR/BS, OcN/Bpm and measurement of serum crosslaps in 3- and 8-month-old female wild-type and S1pr3−/− mice; n=5 mice per group. *P<0.05 versus wild-type. (c) Quantification of mineralization in wild-type and S1pr3−/− primary osteoblasts differentiated for 10 days in the presence of conditioned medium from wild-type osteoclast precursors (Ocl prec.; control) or differentiated osteoclasts being incubated in the absence or presence of CT; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (d) Quantification of mineralization in wild-type and S1pr3−/− primary osteoblasts differentiated for 10 days in the absence or presence of S1P; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (e) Western Blot monitoring Erk1/2 phosphorylation in wild-type and S1pr3−/− primary osteoblasts with or without S1P treatment for 15 min (uncropped blots are presented in Supplementary Fig. 5). All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central
Figure 6 S1P affects gene expression in osteoblasts and accelerates bone turnover. (a) qRT–PCR expression analysis for the indicated genes in wild-type and S1pr3−/− osteoblasts incubated in the absence or presence of S1P for 6 h; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (b) qRT–PCR expression analysis for Col1a1 in wild-type osteoblasts stimulated with S1P in the absence or presence of PD98059 as indicted; n=3 cultures per group. *P<0.05 versus control. (c) qRT–PCR expression analysis for the indicated genes in wild-type and S1pr3−/− osteoblasts incubated in the absence or presence of S1P for 6 h; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (d) Von Kossa/van Gieson-staining of non-decalcified spine sections from 6 weeks old wild-type and Sgpl1−/− mice. Scale bar, 500 μm. (e) Quantification of BV/TV in 3 and 6 weeks old female wild-type and Sgpl1−/− mice; n≥3 mice per group. *P<0.05 versus wild-type. (f) TRAP activity staining reveals a high number of multinucleated osteoclasts (stained in red) in decalcified spine sections from 6 weeks old Sgpl1−/− mice. Scale bar, 50 μm. Quantification of OcN/Bpm is shown on the right; n=3 mice per group. *P<0.05 versus wild-type. (g) Serum crosslaps and PICP concentrations in 6 weeks old female wild-type and Sgpl1−/− mice; n=3 mice per group. *P<0.05 versus wild-type. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 6 S1P affects gene expression in osteoblasts and accelerates bone turnover. (a) qRT–PCR expression analysis for the indicated genes in wild-type and S1pr3−/− osteoblasts incubated in the absence or presence of S1P for 6 h; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (b) qRT–PCR expression analysis for Col1a1 in wild-type osteoblasts stimulated with S1P in the absence or presence of PD98059 as indicted; n=3 cultures per group. *P<0.05 versus control. (c) qRT–PCR expression analysis for the indicated genes in wild-type and S1pr3−/− osteoblasts incubated in the absence or presence of S1P for 6 h; n=3 cultures per group. *P<0.05 versus control. Data are representative of two independent experiments. (d) Von Kossa/van Gieson-staining of non-decalcified spine sections from 6 weeks old wild-type and Sgpl1−/− mice. Scale bar, 500 μm. (e) Quantification of BV/TV in 3 and 6 weeks old female wild-type and Sgpl1−/− mice; n≥3 mice per group. *P<0.05 versus wild-type. (f) TRAP activity staining reveals a high number of multinucleated osteoclasts (stained in red) in decalcified spine sections from 6 weeks old Sgpl1−/− mice. Scale bar, 50 μm. Quantification of OcN/Bpm is shown on the right; n=3 mice per group. *P<0.05 versus wild-type. (g) Serum crosslaps and PICP concentrations in 6 weeks old female wild-type and Sgpl1−/− mice; n=3 mice per group. *P<0.05 versus wild-type. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central
Figure 7 S1pr3-deficiency abrogates the osteoanabolic effect caused by CTR deficiency or FTY720. (a) S1P levels in serum and bones from 6-month-old female wild-type and Calcr−/− mice, and in bones from 6-month-old Calca−/− mice; n=5 mice per group. *P<0.05 versus wild-type controls. (b) Quantification of BV/TV and BFR/BS in 4-month-old female mice of the indicated genotypes; n=5 mice per group. *P<0.05 versus wild-type. (c) Quantification of BV/TV, BFR/BS and OcN/Bpm in 4-month-old female mice of the indicated genotypes receiving daily injections of vehicle or FYT720 at two different doses; n=6 mice per group. *P<0.05 versus vehicle-treated S1pr3+/+ mice. #P<0.05 versus wild-type. (d) Immunohistochemistry for S1P3 in spine sections from wild-type mice (top) and in iliac crest biopsy sections of an individual with Paget’s disease of bone (bottom). Scale bars, 25 μm (top) and 50 μm (bottom). (e) Schematic representation of the proposed function of the CTR in bone formation. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.
Figure 7 S1pr3-deficiency abrogates the osteoanabolic effect caused by CTR deficiency or FTY720. (a) S1P levels in serum and bones from 6-month-old female wild-type and Calcr−/− mice, and in bones from 6-month-old Calca−/− mice; n=5 mice per group. *P<0.05 versus wild-type controls. (b) Quantification of BV/TV and BFR/BS in 4-month-old female mice of the indicated genotypes; n=5 mice per group. *P<0.05 versus wild-type. (c) Quantification of BV/TV, BFR/BS and OcN/Bpm in 4-month-old female mice of the indicated genotypes receiving daily injections of vehicle or FYT720 at two different doses; n=6 mice per group. *P<0.05 versus vehicle-treated S1pr3+/+ mice. #P<0.05 versus wild-type. (d) Immunohistochemistry for S1P3 in spine sections from wild-type mice (top) and in iliac crest biopsy sections of an individual with Paget’s disease of bone (bottom). Scale bars, 25 μm (top) and 50 μm (bottom). (e) Schematic representation of the proposed function of the CTR in bone formation. All error bars indicate s.d. P values were assessed by two-tailed Student’s t-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

Metadata

Authors
Keller, J., Catala-Lehnen, P., Huebner, A. K., Jeschke, A., Heckt, T., Lueth, A., Krause, M., Koehne, T., Albers, J., Schulze, J., Schilling, S., Haberland, M., Denninger, H., Neven, M., Hermans-Borgmeyer, I., Streichert, T., Breer, S., Barvencik, F., Levkau, B., Rathkolb, B., Wolf, E., Calzada-Wack, J., Neff, F., Gailus-Durner, V., Fuchs, H., de Angelis, M. H., Klutmann, S., Tsourdi, E., Hofbauer, L. C., Kleuser, B., Chun, J., Schinke, T., & Amling, M.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • University of Potsdam (DE)
  • Essen University Hospital (DE)
  • Helmholtz Munich (DE)
  • Ludwig-Maximilians-Universität München (DE)
  • Scripps Research Institute (US)
Corresponding author
Amling, Michael
Venue
Nature Communications
Published
2014-10-21
Volume
5
Issue
1
Pages
5215-5215
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1980751002
Cited by
211
References
64
Citations by year
2026: 16 · 2025: 9 · 2024: 16 · 2023: 13 · 2022: 10 · 2021: 27 · 2020: 24 · 2019: 29 · 2018: 16 · 2017: 22 · 2016: 12 · 2015: 15 · 2014: 2
FWCI
6.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • publish.UP (University of Potsdam) (submittedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion)
  • OpenAgrar (submittedVersion)
Funders
  • INFRAFRONTIER (01KX1012)
  • Deutsche Forschungsgemeinschaft (AM103/15-1, DA019674, 01KX1012)
  • Bundesministerium für Bildung und Forschung (01GS0850, 01KX1012, 01GS0851)
  • National Institutes of Health (5r01da019674-05, DA019674)
  • National Institute on Drug Abuse (DA019674, R01-DA019674)
  • National Institute on Deafness and Other Communication Disorders (DC009505, R21DC009505)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
calcitonin, calcitonin receptor, bone formation, osteoclasts, sphingosine-1-phosphate, S1P3 receptor, SPNS2, fingolimod, bone resorption, skeletal phenotype
MeSH terms
Alleles, Animals, Bone and Bones, Calcitonin, Crosses, Genetic, Female, Lysophospholipids, Mice, Inbred C57BL, Mice, Transgenic, Osteoblasts, Osteoclasts, Osteogenesis, Osteoporosis, Phenotype, Sphingosine, Signal Transduction, Porosity, Collagenases, Receptors, Calcitonin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.